Abeona Therapeutics
A commercial-stage biopharmaceutical company developing cell and gene therapies for rare diseases.
About
Pricing
View pricing page ↗
Technology stack
detected 2026-06-23
AWSNo comments yet. Be the first to share your take.
What does Abeona Therapeutics do?
Abeona Therapeutics Inc. is a commercial-stage biopharmaceutical company focused on developing and commercializing cell and gene therapies for serious and life-threatening rare diseases. Their lead product, ZEVASKYN (prademagene zamikeracel), is an autologous cell-based gene therapy for recessive dystrophic epidermolysis bullosa (RDEB). The company also has a pipeline of AAV-based gene therapies for ophthalmic and other rare genetic disorders.
Where is Abeona Therapeutics headquartered?
Abeona Therapeutics is headquartered in Cleveland, United States.
When was Abeona Therapeutics founded?
Abeona Therapeutics was founded in 1974.
What industry does Abeona Therapeutics operate in?
Abeona Therapeutics operates in Biotech, Gene Therapy, Rare Diseases.
How many employees does Abeona Therapeutics have?
Abeona Therapeutics has approximately 229 people on record.